Xiao Ding,Robert H. Hyland,Phillip S. Pang,William Thomas Symonds, III
申请号：
US14195751
公开号：
US20140249101A1
申请日:
2014.03.03
申请国别(地区):
US
年份:
2014
代理人:
摘要：
Disclosed herein is a method of treating a subject infected with hepatitis C virus, said method comprising administering to the subject for a time period an effective amount of sofosbuvir, an effective amount of ribavirin and an effective amount of ledipasvir. In one aspect, the method comprises administering to the subject an interferon-free treatment regimen comprising an effective amount of sofosbuvir, an effective amount of ribavirin and an effective amount of ledipasvir. In a particular aspect, the method is sufficient to produce an undetectable amount of HCV RNA in the subject for at least 12 weeks after the end of the time period.
